{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:56:35Z","timestamp":1794012995783,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["CY2021-QN-A20"],"award-info":[{"award-number":["CY2021-QN-A20"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022817","name":"Lanzhou University Second Hospital","doi-asserted-by":"publisher","award":["22YF7FA090"],"award-info":[{"award-number":["22YF7FA090"]}],"id":[{"id":"10.13039\/100022817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.phrs.2025.107695","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:43:43Z","timestamp":1742053423000},"page":"107695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation"],"prefix":"10.1016","volume":"215","author":[{"given":"Chenyang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107695_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.phrs.2025.107695_bib2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2025.107695_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","article-title":"Molecular and histopathology directed therapy for advanced bladder cancer","volume":"16","author":"Alifrangis","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.phrs.2025.107695_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11912-018-0727-5","article-title":"Molecular Subtypes of Bladder Cancer","volume":"20","author":"McConkey","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.phrs.2025.107695_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.semnuclmed.2020.02.006","article-title":"Targets for Therapy of Bladder Cancer","volume":"50","author":"Seidl","year":"2020","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.phrs.2025.107695_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107695_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2025.107695_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000012","article-title":"Therapeutic Targeting of Cancer Metabolism with Triosephosphate Isomerase","volume":"17","author":"Pekel","year":"2020","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.phrs.2025.107695_bib9","article-title":"Clinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancer","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2025.107695_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1101\/gr.6.4.314","article-title":"A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13","volume":"6","author":"Ansari-Lari","year":"1996","journal-title":"Genome Res"},{"key":"10.1016\/j.phrs.2025.107695_bib11","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1016\/S0021-9258(19)83687-6","article-title":"Human triosephosphate isomerase cDNA and protein structure. Studies of triosephosphate isomerase deficiency in man","volume":"260","author":"Maquat","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107695_bib12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jcb.21727","article-title":"Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma","volume":"104","author":"Qi","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.phrs.2025.107695_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1021\/pr0602287","article-title":"Identification of Tumor Antigens in Human Lung Squamous Carcinoma by Serological Proteome Analysis","volume":"6","author":"Yang","year":"2007","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.phrs.2025.107695_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3858\/emm.2008.40.6.709","article-title":"Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model","volume":"40","author":"Kim","year":"2008","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.phrs.2025.107695_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110137","article-title":"Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis","volume":"37","author":"Duan","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2025.107695_bib16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00535-020-01729-0","article-title":"Proteomics analysis identified TPI1 as a novel biomarker for predicting recurrence of intrahepatic cholangiocarcinoma","volume":"55","author":"Yu","year":"2020","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.107695_bib17","first-page":"2","article-title":"17-Molecular determinants of outcome in bladder cancer","volume":"5","author":"Cote","year":"1999","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/j.phrs.2025.107695_bib18","unstructured":"Livingston R., Sprouse J., Jacks T., Tlsty\u2019t T.D. Altered Cell Cycle Arrest and Gene Amplification Potential Accompany Loss of Wild-Type \u223c53 n.d."},{"key":"10.1016\/j.phrs.2025.107695_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107695_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fonc.2020.00102","article-title":"Traditional Classification and Novel Subtyping Systems for Bladder Cancer","volume":"10","author":"Zhu","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.phrs.2025.107695_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5858\/arpa.2011-0471-RA","article-title":"Emerging Critical Role of Molecular Testing in Diagnostic Genitourinary Pathology","volume":"136","author":"Netto","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.phrs.2025.107695_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.4.110807.092230","article-title":"Molecular Pathogenesis and Diagnostics of Bladder Cancer","volume":"4","author":"Mitra","year":"2009","journal-title":"Annu Rev. Pathol. Mech. Dis."},{"key":"10.1016\/j.phrs.2025.107695_bib23","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.107695_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae243","article-title":"irGSEA: the integration of single-cell rank-based gene set enrichment analysis","volume":"25","author":"Fan","year":"2024","journal-title":"Brief. Bioinforma."},{"key":"10.1016\/j.phrs.2025.107695_bib25","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2025.107695_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3892\/ijo.2023.5532","article-title":"Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR\/PI3K\/AKT pathway","volume":"63","author":"Li","year":"2023","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.phrs.2025.107695_bib27","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.2023020731","article-title":"The role of the MDM2\/p53 axis in antitumor immune responses","volume":"143","author":"Brummer","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2025.107695_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12935-024-03356-8","article-title":"MDM2: current research status and prospects of tumor treatment","volume":"24","author":"Yao","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.phrs.2025.107695_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400935121","article-title":"Induction of the Mdm2 gene and protein by kinase signaling pathways is repressed by the pVHL tumor suppressor","volume":"121","author":"Mabry","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107695_bib30","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1128\/MCB.25.16.7170-7180.2005","article-title":"Glycogen Synthase Kinase 3-Dependent Phosphorylation of Mdm2 Regulates p53 Abundance","volume":"25","author":"Kulikov","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2025.107695_bib31","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41467-023-38430-8","article-title":"Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK\/MDM2\/p53 axis","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107695_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217156","article-title":"Glycolysis, the sweet appetite of the tumor microenvironment","volume":"600","author":"Kooshan","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2025.107695_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12967-025-06138-6","article-title":"Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107695_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70242","article-title":"PGK1 can affect the prognosis and development of bladder cancer","volume":"13","author":"Gao","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.phrs.2025.107695_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12935-021-02303-1","article-title":"Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.phrs.2025.107695_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216964","article-title":"Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation","volume":"593","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2025.107695_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113247","article-title":"Pterostilbene suppresses the growth of esophageal squamous cell carcinoma by inhibiting glycolysis and PKM2\/STAT3\/c-MYC signaling pathway","volume":"142","author":"Yang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.107695_bib38","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1016\/j.molcel.2024.07.025","article-title":"Nuclear PKM2 binds pre-mRNA at folded G-quadruplexes and reveals their gene regulatory role","volume":"84","author":"Anastasakis","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.107695_bib39","article-title":"TMEM52B Isoforms P18 and P20 Differentially Promote the Oncogenesis and Metastasis of Nasopharyngeal Carcinoma","author":"Zhu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2025.107695_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-00418-x","article-title":"Targeting the ubiquitination\/deubiquitination process to regulate immune checkpoint pathways","volume":"6","author":"Liu","year":"2021","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.phrs.2025.107695_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.dnarep.2009.01.008","article-title":"p53 ubiquitination by Mdm2: A never ending tail?","volume":"8","author":"Coutts","year":"2009","journal-title":"DNA Repair"},{"key":"10.1016\/j.phrs.2025.107695_bib42","doi-asserted-by":"crossref","first-page":"a026336","DOI":"10.1101\/cshperspect.a026336","article-title":"The Role of MDM2 Amplification and Overexpression in Tumorigenesis","volume":"6","author":"Oliner","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.phrs.2025.107695_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202300006","article-title":"Nutlin-3a-aa: Improving the Bioactivity of a p53\/MDM2 Interaction Inhibitor by Introducing a Solvent-Exposed Methylene Group","volume":"24","author":"Nietzold","year":"2023","journal-title":"ChemBioChem"},{"key":"10.1016\/j.phrs.2025.107695_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/ml4000657","article-title":"Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development","volume":"4","author":"Vu","year":"2013","journal-title":"ACS Med Chem. Lett."},{"key":"10.1016\/j.phrs.2025.107695_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13045-017-0500-5","article-title":"MDM2\/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer","volume":"10","author":"Tisato","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2025.107695_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:45:11Z","timestamp":1762353911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":46,"alternative-id":["S1043661825001203"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107695","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107695"}}